The post Solana (SOL) Price Prediction: Q4 Growth Potential and Viral Altcoin to Watch for 25-50x Gains appeared on BitcoinEthereumNews.com. As Solana (SOL) continues to draw traders’ attention with its robust network performance and growing ecosystem, market analysts are eyeing its Q4 trajectory with cautious optimism. However, the real buzz in the crypto market is surrounding Mutuum Finance (MUTM), an emerging DeFi player being tipped as a potential viral altcoin capable of delivering 25x–50x gains. The project’s presale token price is at $0.035 in phase 6. Experts assert that the new token can explode with phenomenal gains in the coming months. It will increase by 14.29% to $0.04 in phase 7. Mutuum Finance (MUTM) has already raised over $15.25 million and has been supported by more than 15,850 investors. Mutuum Finance is setting the stage for a dynamic close to 2025. Solana (SOL) Outlook: On Track for Potential Breakout Solana is currently trading at $215.91, gaining ground as its price hovers near short-term resistance. Analysts highlight strengthened on-chain fundamentals, particularly growing DEX volume, rising whale activity, and upcoming network upgrades like the Alpenglow protocol, as key drivers that could support a breakout beyond the $220–$235 zone, possibly paving the way toward targets in the $250–$300 range. Investors FOMO into Mutuum Finance (MUTM) Stage 6 Presale Mutuum Finance (MUTM) is currently priced at $0.035 in presale stage 6. More than $15.25 million have been collected and more than 15850 early investors have joined the presale. Token price in Presale Stage 7 will be $0.04, which is a 14.3% increase from Stage 6. Mutuum Finance (MUTM) has announced its Official Bug Bounty Program through CertiK. Its users will receive a share of the program’s reward of $50,000 USDT if they are able to spot possible bugs in the project.  Its bounty program is created to provide equal security to all types of vulnerabilities. The program is categorized into four classes of severity;… The post Solana (SOL) Price Prediction: Q4 Growth Potential and Viral Altcoin to Watch for 25-50x Gains appeared on BitcoinEthereumNews.com. As Solana (SOL) continues to draw traders’ attention with its robust network performance and growing ecosystem, market analysts are eyeing its Q4 trajectory with cautious optimism. However, the real buzz in the crypto market is surrounding Mutuum Finance (MUTM), an emerging DeFi player being tipped as a potential viral altcoin capable of delivering 25x–50x gains. The project’s presale token price is at $0.035 in phase 6. Experts assert that the new token can explode with phenomenal gains in the coming months. It will increase by 14.29% to $0.04 in phase 7. Mutuum Finance (MUTM) has already raised over $15.25 million and has been supported by more than 15,850 investors. Mutuum Finance is setting the stage for a dynamic close to 2025. Solana (SOL) Outlook: On Track for Potential Breakout Solana is currently trading at $215.91, gaining ground as its price hovers near short-term resistance. Analysts highlight strengthened on-chain fundamentals, particularly growing DEX volume, rising whale activity, and upcoming network upgrades like the Alpenglow protocol, as key drivers that could support a breakout beyond the $220–$235 zone, possibly paving the way toward targets in the $250–$300 range. Investors FOMO into Mutuum Finance (MUTM) Stage 6 Presale Mutuum Finance (MUTM) is currently priced at $0.035 in presale stage 6. More than $15.25 million have been collected and more than 15850 early investors have joined the presale. Token price in Presale Stage 7 will be $0.04, which is a 14.3% increase from Stage 6. Mutuum Finance (MUTM) has announced its Official Bug Bounty Program through CertiK. Its users will receive a share of the program’s reward of $50,000 USDT if they are able to spot possible bugs in the project.  Its bounty program is created to provide equal security to all types of vulnerabilities. The program is categorized into four classes of severity;…

Solana (SOL) Price Prediction: Q4 Growth Potential and Viral Altcoin to Watch for 25-50x Gains

As Solana (SOL) continues to draw traders’ attention with its robust network performance and growing ecosystem, market analysts are eyeing its Q4 trajectory with cautious optimism. However, the real buzz in the crypto market is surrounding Mutuum Finance (MUTM), an emerging DeFi player being tipped as a potential viral altcoin capable of delivering 25x–50x gains.

The project’s presale token price is at $0.035 in phase 6. Experts assert that the new token can explode with phenomenal gains in the coming months. It will increase by 14.29% to $0.04 in phase 7. Mutuum Finance (MUTM) has already raised over $15.25 million and has been supported by more than 15,850 investors. Mutuum Finance is setting the stage for a dynamic close to 2025.

Solana (SOL) Outlook: On Track for Potential Breakout

Solana is currently trading at $215.91, gaining ground as its price hovers near short-term resistance. Analysts highlight strengthened on-chain fundamentals, particularly growing DEX volume, rising whale activity, and upcoming network upgrades like the Alpenglow protocol, as key drivers that could support a breakout beyond the $220–$235 zone, possibly paving the way toward targets in the $250–$300 range.

Investors FOMO into Mutuum Finance (MUTM) Stage 6 Presale

Mutuum Finance (MUTM) is currently priced at $0.035 in presale stage 6. More than $15.25 million have been collected and more than 15850 early investors have joined the presale. Token price in Presale Stage 7 will be $0.04, which is a 14.3% increase from Stage 6.

Mutuum Finance (MUTM) has announced its Official Bug Bounty Program through CertiK. Its users will receive a share of the program’s reward of $50,000 USDT if they are able to spot possible bugs in the project. 

Its bounty program is created to provide equal security to all types of vulnerabilities. The program is categorized into four classes of severity; i.e., major, minor, low, and critical.

Mutuum Finance Announces Huge Token Giveaway

Mutuum Finance (MUTM) has also initiated a  $100,000 giveaway, where the users will be rewarded in the form of $10,000 MUTM tokens. Mutuum Finance (MUTM) is building an overcollateralized USD-backed stablecoin on the Ethereum blockchain. The project is also audited and verified by CertiK.

The Future of Decentralized Lending

Mutuum Finance DeFi protocol enables decentralized lending where users retain complete ownership of the assets while lending. Passive income for lenders and borrowers are auto-credited and accessed, respectively, by collateralizing diversified assets while lending. Systematic rate adjustment is pre-set by the system for optimal capital structure and ecosystem sustainability.

Mutuum Finance (MUTM) offers users a double-lending opportunity with first-rate flexibility using Peer-to-Contract (P2C) and Peer-to-Peer (P2P) models. Peer-to-Contract (P2C) model is smart contract-powered to control lending pools that dynamically adjust interest levels in precise parallel with the market. Lenders are offered secured returns, while the borrowers are provided secure options on borrowing capital on loan.

Peer-to-Peer (P2P) eliminates the intermediaries as it enables borrowing parties to interact directly with lending agents. High-risk investments like meme coins require the type of fully decentralized infrastructure that enables users to be in complete control.

Mutuum Finance (MUTM) has already raised over $15.25 million from more than 15,850 participants during its presale. With the next stage set at $0.04 and its dual-lending protocol, bug bounty, and upcoming stablecoin gaining traction, the project is aligning for significant upside potential in Q4. Investors aiming for early positioning ahead of its projected 25x–50x growth window may find this presale stage to be the most strategic point of entry before broader market momentum builds.

For more information about Mutuum Finance (MUTM) visit the links below:

Website: https://mutuum.com/

Linktree: https://linktr.ee/mutuumfinance

Source: https://www.cryptopolitan.com/q4-growth-potential-and-viral-altcoin-to-watch-for-25-50x-gains/

Market Opportunity
NEAR Logo
NEAR Price(NEAR)
$1.727
$1.727$1.727
-1.08%
USD
NEAR (NEAR) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26